CymitQuimica logo

CAS 109351-34-0

:

(R)-Terazosina

Formula:C19H25N5O4
Sinonimi:
  • Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, (R)-
  • Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[[(2R)-tetrahydro-2-furanyl]carbonyl]- (9CI)
  • (R)-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone
  • (R)-Terazosin
  • Terazosin-002-R
  • Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(2R)-tetrahydro-2-furanyl]-
Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 5 prodotti.
  • (R)-Terazosin

    CAS:
    R-Terazosin is the active R-enantiomer and potent α1-adrenoceptor antagonist (Ki: α1a 6.51 nM, α1b 1.01 nM, α1d 1.97 nM).
    Formula:C19H25N5O4
    Purezza:98.96% - 99.79%
    Colore e forma:Solid
    Peso molecolare:387.43

    Ref: TM-T12643

    500mg
    Prezzo su richiesta
    1mg
    44,00€
    2mg
    60,00€
    5mg
    90,00€
    1mL*10mM (DMSO)
    100,00€
    10mg
    138,00€
    25mg
    227,00€
    50mg
    334,00€
    100mg
    469,00€
  • (R)-Terazosin

    CAS:
    (R)-Terazosin
    Formula:C19H25N5O4
    Purezza:≥98%
    Peso molecolare:387.43

    Ref: 54-BUP09057

    2mg
    93,00€
    5mg
    147,00€
    10mg
    211,00€
    25mg
    343,00€
    50mg
    502,00€
    100mg
    679,00€
  • (R)-Terazosin

    CAS:
    (R)-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone
    Formula:C19H25N5O4
    Purezza:99%
    Peso molecolare:387.43

    Ref: IN-DG00840492

    10mg
    129,00€
    25mg
    225,00€
    50mg
    364,00€
    100mg
    599,00€
    250mg
    1.139,00€
  • (R)-Terazosin

    Prodotto controllato
    CAS:
    Formula:C19H25N5O4
    Colore e forma:Neat
    Peso molecolare:387.43

    Ref: TR-T105015

    5mg
    1.008,00€
  • (R)-Terazosin

    CAS:
    Terazosin is an alpha-adrenergic receptor antagonist that is used to treat benign prostatic hyperplasia, prostate cancer, and urinary incontinence. It is not a prodrug and does not have any active metabolites. Terazosin inhibits the binding of n-methyl-d-aspartic acid (NMDA) to its receptors in the central nervous system and may act as an NMDA antagonist. Terazosin also binds to soluble guanylate cyclase, which regulates nitric oxide production, leading to relaxation of smooth muscle cells in blood vessels. The drug has been shown to be effective in treating prostate cancer cells in vitro by inhibiting the growth of these cells at concentrations between 10 µM and 1 mM. Terazosin may inhibit the activity of long-term treatment with caco-2 cells at concentrations between 0.1 µM and 100 µM. Terazosin has been shown to bind ferrite at concentrations greater than 100
    Formula:C19H25N5O4
    Purezza:Min. 95%
    Peso molecolare:387.4 g/mol

    Ref: 3D-JEA35134

    50mg
    6.010,00€